233 related articles for article (PubMed ID: 18547542)
1. The MacDQoL individualized measure of the impact of macular degeneration on quality of life: reliability and responsiveness.
Mitchell J; Wolffsohn J; Woodcock A; Anderson SJ; Ffytche T; Rubinstein M; Amoaku W; Bradley C
Am J Ophthalmol; 2008 Sep; 146(3):447-454. PubMed ID: 18547542
[TBL] [Abstract][Full Text] [Related]
2. +Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life.
Mitchell J; Wolffsohn JS; Woodcock A; Anderson SJ; McMillan CV; Ffytche T; Rubinstein M; Amoaku W; Bradley C
Health Qual Life Outcomes; 2005 Apr; 3():25. PubMed ID: 15831093
[TBL] [Abstract][Full Text] [Related]
3. Vision-related quality of life in patients with bilateral severe age-related macular degeneration.
Cahill MT; Banks AD; Stinnett SS; Toth CA
Ophthalmology; 2005 Jan; 112(1):152-8. PubMed ID: 15629836
[TBL] [Abstract][Full Text] [Related]
4. Reliability, validity and responsiveness of the Greek MacDQoL individualized measure of the impact of macular degeneration on quality of life.
Marakis TP; Koutsandrea C; Chatzistefanou KI; Tountas Y
Qual Life Res; 2017 Jan; 26(1):183-191. PubMed ID: 27614659
[TBL] [Abstract][Full Text] [Related]
5. Vision-related quality of life in patients suffering from age-related macular degeneration.
Berdeaux GH; Nordmann JP; Colin E; Arnould B
Am J Ophthalmol; 2005 Feb; 139(2):271-9. PubMed ID: 15733988
[TBL] [Abstract][Full Text] [Related]
6. Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration.
Cahill MT; Stinnett SS; Banks AD; Freedman SF; Toth CA
Ophthalmology; 2005 Jan; 112(1):144-51. PubMed ID: 15629835
[TBL] [Abstract][Full Text] [Related]
7. Psychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25), Japanese version.
Suzukamo Y; Oshika T; Yuzawa M; Tokuda Y; Tomidokoro A; Oki K; Mangione CM; Green J; Fukuhara S
Health Qual Life Outcomes; 2005 Oct; 3():65. PubMed ID: 16248900
[TBL] [Abstract][Full Text] [Related]
8. Impact of cataract surgery on quality of life in patients with early age-related macular degeneration.
Lamoureux EL; Hooper CY; Lim L; Pallant JF; Hunt N; Keeffe JE; Guymer RH
Optom Vis Sci; 2007 Aug; 84(8):683-8. PubMed ID: 17700333
[TBL] [Abstract][Full Text] [Related]
9. Rasch analysis reveals problems with multiplicative scoring in the macular disease quality of life questionnaire.
Finger RP; Fenwick E; Pesudovs K; Marella M; Lamoureux EL; Holz FG
Ophthalmology; 2012 Nov; 119(11):2351-7. PubMed ID: 22968142
[TBL] [Abstract][Full Text] [Related]
10. Assessing participation in daily living and the effectiveness of rehabiliation in age related macular degeneration patients using the impact of vision impairment scale.
Lamoureux EL; Pallant JF; Pesudovs K; Tennant A; Rees G; O'Connor PM; Keeffe JE
Ophthalmic Epidemiol; 2008; 15(2):105-13. PubMed ID: 18432494
[TBL] [Abstract][Full Text] [Related]
11. [Visual function and quality of life in patients with age-related maculopathy: results of the Münster Age and Retina Study (MARS)].
Fuhs A; Dasch B; Behrens T; Meister A; Krause K; Pauleikhoff D; Hense HW
Klin Monbl Augenheilkd; 2005 Aug; 222(8):649-54. PubMed ID: 16118746
[TBL] [Abstract][Full Text] [Related]
12. Reading performance with low-vision aids and vision-related quality of life after macular translocation surgery in patients with age-related macular degeneration.
Nguyen NX; Besch D; Bartz-Schmidt K; Gelisken F; Trauzettel-Klosinski S
Acta Ophthalmol Scand; 2007 Dec; 85(8):877-82. PubMed ID: 17651462
[TBL] [Abstract][Full Text] [Related]
13. Metric properties of the MacDQoL, individualized macular-disease-specific quality of life instrument, and newly identified subscales in French, German, Italian, and American populations.
Berdeaux G; Mesbah M; Bradley C
Value Health; 2011 Jan; 14(1):110-20. PubMed ID: 21211493
[TBL] [Abstract][Full Text] [Related]
14. Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials.
Suñer IJ; Kokame GT; Yu E; Ward J; Dolan C; Bressler NM
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3629-35. PubMed ID: 19255158
[TBL] [Abstract][Full Text] [Related]
15. Vision-related quality of life and visual function after retinal detachment surgery.
Okamoto F; Okamoto Y; Hiraoka T; Oshika T
Am J Ophthalmol; 2008 Jul; 146(1):85-90. PubMed ID: 18400201
[TBL] [Abstract][Full Text] [Related]
16. Public health impact of neovascular age-related macular degeneration treatments extrapolated from visual acuity.
Bandello F; Lafuma A; Berdeaux G
Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):96-103. PubMed ID: 17197522
[TBL] [Abstract][Full Text] [Related]
17. Cross-validation of the Turkish version of the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ 25).
Toprak AB; Eser E; Guler C; Baser FE; Mayali H
Ophthalmic Epidemiol; 2005 Aug; 12(4):259-69. PubMed ID: 16033747
[TBL] [Abstract][Full Text] [Related]
18. Visual function and subjective quality of life compared in subjects with acquired macular disease.
Hazel CA; Petre KL; Armstrong RA; Benson MT; Frost NA
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1309-15. PubMed ID: 10798645
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of minimum clinically meaningful changes in scores on the National Eye Institute Visual Function Questionnaire (NEI-VFQ) SST Report Number 19.
Submacular Surgery Trials Research Group
Ophthalmic Epidemiol; 2007; 14(4):205-15. PubMed ID: 17896299
[TBL] [Abstract][Full Text] [Related]
20. Quality of life in patients with age-related macular degeneration: impact of the condition and benefits of treatment.
Slakter JS; Stur M
Surv Ophthalmol; 2005; 50(3):263-73. PubMed ID: 15850815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
